Secures $2 Million Investment from Cedars-Sinai and Oxford Science Enterprises to Revolutionise Neurology Care —
Summary
This funding marks the launch of a groundbreaking partnership between the two organizations to co-build and co-invest in health-tech startups, accelerating their growth in the U.S. and U.K. markets.The investment will support Neu Healths expansion into the U.S., starting with a six-month pilot program at Cedars-Sinai. The platforms patient-centric design supports improved symptom monitoring, tailored care plans, and proactive clinical interventions. The Neu Health technology will enable clinicians, patients and family caregivers to take major steps forward in managing these diseases. With a focus on Life Sciences, Health Tech, and Deep Tech, OSE has invested over \xa32.5 billion in groundbreaking companies addressing some of the worlds greatest challenges.About Cedars-Sinai Cedars-Sinai is a leading nonprofit healthcare organization based in Los Angeles, California, known for its dedication to providing high-quality patient care, innovative research, and advanced medical education. Through strategic initiatives like this partnership, Cedars-Sinai aims to advance patient-centered health-tech solutions and improve healthcare outcomes globally.